The nation of Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive biological samples.
This move became public following a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson later explained that the US was demanding access to genetic material for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more talks to secure a agreement acceptable to both sides so the nation's critical HIV treatment initiative can continue.
Wider Implications
Zimbabwe's decision follows a similar situation in Kenya, where a court blocked a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government deals to boost openness and responsibility.
As per statements, 16 nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would supply the basic resources for scientific discovery without any assurance that the resulting innovations would be available to our population should a future pandemic emerge."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.
"This framework is intended to guarantee that when a country contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how future co-operation might be arranged in a way that respects the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations need to persist given that much of the nation's HIV programmes depended on external financing.
"In cases where specific concerns arise, such as those involving information security or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.
This impasse underscores the continuing debate between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.